Since their drug is TNF specific does it mean it targets TNF-Alpha more specifically than Leronlimab?

I definitely found it interesting. Sounds like a one trick show as Leronlimab works on a entire host of things.

83 patients with stat sig is still sorta impressive right ?

Leronlimab is goin to knock this out of the park!

Thanks Ohm